In a session at #AMCPNexus 2022, speakers discussed the rise in #stimulant #overdoses with an emphasis on treatment options and how providers and health plans can better manage patients with stimulant use disorder. buff.ly/3yOl1ou

A Class II #recall has been issued for 103,150 vials of a #prescription bronchodilator following the report of a hair found in a vial. buff.ly/3yMsDIk

Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients. buff.ly/3eQOR58

Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting #Pharmaceutical interventions for #patientsafety. buff.ly/3VIdnWG

Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, conference coverage, and more with thought leaders in #PopulationHealth and more! buff.ly/35pWM0Q

Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical #pharmacy services. buff.ly/3DaskIO

In the latest installment of Talking Therapeutics, Dr Jennings shares a randomized study in which patients with mild to moderate cases of #COVID19 were treated with either ivermectin or placebo. buff.ly/3flnZdH

Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending #trends that emerged over the course of 2021 and predicts how spending will continue to change. buff.ly/3fHbpWd

A Class I #Recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel. buff.ly/3Wx1zH9

Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world. buff.ly/3fQ5sGy

In the latest issue of Talking Therapeutics, Dr Jennings highlights #data from American Heart Association Scientific Sessions 2022, including research into direct oral anticoagulants, a novel fibrate, and more. buff.ly/3Ut9yDH

In the second part of his coverage of AHA Scientific Sessions 2022, Dr Jennings shares 2 randomized trials designed to compare diuretics for the treatment of hypertension and #HeartFailure buff.ly/3gdpzil

Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the #Omicron subvariants BQ.1 and BQ.1.1. buff.ly/3V12j65

Check out our #quiz and test your knowledge on the recommended dosage of an H2 blocker for gastroesophageal reflux disease. buff.ly/3VwlQeH

Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout? buff.ly/3Uihjve

Nicole L Stout, DPT, CLT-LANA, FAPTA, shares her team’s research on distress screening and a quality improvement project to boost provider efficiency and close gaps in patients’ cancer #care buff.ly/3gFQ0xp

Several lots of hand sanitizer are being recalled after the US Food and Drug Administration found undeclared methanol in one. buff.ly/3EPe2xL

A prescription #drug used to manage hypertension is being recalled due to potential cross contamination. buff.ly/3EVlaZw

A Class II #recall has been issued for a #prescription #Medication used to reverse the effects of nondepolarizing neuromuscular blocking agents after surgery. buff.ly/3uc8usn

Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease. buff.ly/3iiUHxp